Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB31734ExperimentalSmall molecule
FRAX597 is a small molecule drug that inhibits the p21-activated kinases (PAKs).
- Mechanism
- Curator reviewed · 2 references
FRAX597 is a potent ATP-competitive inhibitor of the group I p21-activated kinases (PAKs) which includes PAK1, PAK2, and PAK3.
- Formula / weight
- C29H28ClN7OS · 558.1 g/mol (avg)
- Code names
- FRAX597
Resolves to
Structure
InChIKey
DHUJCQOUWQMVCG-UHFFFAOYSA-NSMILESCCN1C(=O)C(=CC2=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C12)C1=C(Cl)C=C(C=C1)C1=CN=CS1What you can answer from here — as of August 31, 2026
3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with FRAX597, and which of those have an active Phase 3 trial?